Literature DB >> 31320242

Neutrophil-to-lymphocyte ratio as an indicator of prognosis in patients with pancreatic cancer.

Tomoyuki Kawada1.   

Abstract

Entities:  

Year:  2019        PMID： 31320242     DOI： 10.1016/j.hpb.2019.06.010

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN： 1365-182X            Impact factor:   3.647


× No keyword cloud information.
  2 in total

1.  Systemic Immune-Inflammation Index and Changes of Neutrophil-Lymphocyte Ratio as Prognostic Biomarkers for Patients With Pancreatic Cancer Treated With Immune Checkpoint Blockade.

Authors:  Jin Shang; Xiao Han; Haoran Zha; Haitao Tao; Xiaoyan Li; Fang Yuan; Guangying Chen; Lijie Wang; Junxun Ma; Yi Hu
Journal:  Front Oncol       Date:  2021-02-24       Impact factor: 6.244

2.  Antibiotic use influences outcomes in advanced pancreatic adenocarcinoma patients.

Authors:  Chirayu Mohindroo; Merve Hasanov; Jane E Rogers; Wenli Dong; Laura R Prakash; Seyda Baydogan; Jonathan D Mizrahi; Michael J Overman; Gauri R Varadhachary; Robert A Wolff; Milind M Javle; David R Fogelman; Michael T Lotze; Michael P Kim; Matthew H G Katz; Shubham Pant; Ching-Wei D Tzeng; Florencia McAllister
Journal:  Cancer Med       Date:  2021-07-11       Impact factor: 4.452
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.